title: Interview: stabilization of biological assays: conventional versus new technology. Interview by Lauren Constable.
abstract: Miles Burrows speaks to Lauren Constable, Head of Commissioning Following completion of his PhD in Chemistry at Cardiff University (UK), Miles Burrows started his career at Amersham Biosciences (UK), predominately researching fluorescent reagents and the labeling of biological compounds. Following the acquisition of Amersham by GE Healthcare (UK), Burrows took on the role of R&D Technology Manager, leading a multifunctional team of chemists, biologists and industrial design engineers through new product introduction, research and product care projects. During this period, Burrows oversaw the launch of a custom assay stabilization service based on the well-established technology as used in GE Healthcare's Ready-To-Go™ product range. Since 2012 Burrows has been the Global Product Manager for custom molecular biology and fluorescent reagents for GE Healthcare Life Sciences.
authors.affiliation: GE Healthcare UK Limited, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA, UK. miles.burrows@ge.com.
authors.forename: Miles
authors.initials: M
authors.lastname: Burrows
mesh_terms: D001681:Biological Assay / Q000191:economics / Q000592:standards*; D015415:Biomarkers / Q000032:analysis*; D004345:Drug Industry / Q000592:standards; D006801:Humans; D019095:Point-of-Care Systems; D013696:Temperature
chemical_list: D015415:Biomarkers